| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,305 |
43,017 |
$2.46M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,104 |
17,987 |
$1.46M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,196 |
10,196 |
$775K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,164 |
3,164 |
$381K |
| 99051 |
|
44,233 |
43,998 |
$366K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,156 |
5,137 |
$212K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,413 |
11,017 |
$186K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,943 |
1,943 |
$110K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,971 |
2,552 |
$74K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,113 |
6,095 |
$63K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,564 |
1,544 |
$52K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
816 |
813 |
$42K |
| 99215 |
Prolong outpt/office vis |
81 |
80 |
$9K |
| 81025 |
|
1,249 |
1,248 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
112 |
112 |
$3K |
| 87807 |
|
131 |
131 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
43 |
$683.84 |
| 36415 |
Collection of venous blood by venipuncture |
264 |
264 |
$665.55 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
26 |
$360.49 |
| 99050 |
|
29 |
29 |
$203.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
117 |
117 |
$89.76 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
12 |
12 |
$7.20 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$1.95 |
| 81003 |
|
12 |
12 |
$0.00 |